These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 21636655)
1. Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats. Levin ED; Johnson JE; Slade S; Wells C; Cauley M; Petro A; Rose JE J Pharmacol Exp Ther; 2011 Sep; 338(3):890-6. PubMed ID: 21636655 [TBL] [Abstract][Full Text] [Related]
2. Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D DiPalma D; Rezvani AH; Willette B; Wells C; Slade S; Hall BJ; Levin ED Pharmacol Biochem Behav; 2019 Jan; 176():16-22. PubMed ID: 30419272 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles. Higgins GA; Silenieks LB; Lau W; de Lannoy IA; Lee DK; Izhakova J; Coen K; Le AD; Fletcher PJ Psychopharmacology (Berl); 2013 Apr; 226(3):475-90. PubMed ID: 23184281 [TBL] [Abstract][Full Text] [Related]
4. The Serotonin 2C Receptor Agonist Lorcaserin Attenuates Intracranial Self-Stimulation and Blocks the Reward-Enhancing Effects of Nicotine. Zeeb FD; Higgins GA; Fletcher PJ ACS Chem Neurosci; 2015 Jul; 6(7):1231-40. PubMed ID: 25781911 [TBL] [Abstract][Full Text] [Related]
7. IV nicotine self-administration in rats using a consummatory operant licking response: sensitivity to serotonergic, glutaminergic and histaminergic drugs. Cousins V; Rose JE; Levin ED Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():200-5. PubMed ID: 24953434 [TBL] [Abstract][Full Text] [Related]
8. Directly Observable Behavioral Effects of Lorcaserin in Rats. Serafine KM; Rice KC; France CP J Pharmacol Exp Ther; 2015 Dec; 355(3):381-5. PubMed ID: 26384326 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats. Gannon BM; Sulima A; Rice KC; Collins GT J Pharmacol Exp Ther; 2018 Mar; 364(2):359-366. PubMed ID: 29217539 [TBL] [Abstract][Full Text] [Related]
10. Preclinical evidence for combining the 5-HT Fletcher PJ; Li Z; Silenieks LB; MacMillan C; DeLannoy I; Higgins GA Addict Biol; 2019 May; 24(3):376-387. PubMed ID: 29498158 [TBL] [Abstract][Full Text] [Related]
11. Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats. Levin ED; Slade S; Johnson M; Petro A; Horton K; Williams P; Rezvani AH; Rose JE Eur J Pharmacol; 2008 Dec; 600(1-3):93-7. PubMed ID: 18950618 [TBL] [Abstract][Full Text] [Related]
12. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats. Hayes DJ; Mosher TM; Greenshaw AJ Behav Brain Res; 2009 Feb; 197(2):323-30. PubMed ID: 18805442 [TBL] [Abstract][Full Text] [Related]
15. Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats. Neelakantan H; Holliday ED; Fox RG; Stutz SJ; Comer SD; Haney M; Anastasio NC; Moeller FG; Cunningham KA ACS Chem Neurosci; 2017 May; 8(5):1065-1073. PubMed ID: 28107783 [TBL] [Abstract][Full Text] [Related]
16. Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats. Levin ED; Rezvani AH; Xiao Y; Slade S; Cauley M; Wells C; Hampton D; Petro A; Rose JE; Brown ML; Paige MA; McDowell BE; Kellar KJ J Pharmacol Exp Ther; 2010 Mar; 332(3):933-9. PubMed ID: 20007754 [TBL] [Abstract][Full Text] [Related]
17. Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine. Grottick AJ; Corrigall WA; Higgins GA Psychopharmacology (Berl); 2001 Sep; 157(3):292-8. PubMed ID: 11605085 [TBL] [Abstract][Full Text] [Related]